While the advance of molecular genetic testing was believed to provide strong support to the diagnosis, in a large French study covering 821 cases suspicious with CAPS, only 16% of the cases were identified with NLRP3 mutations10. Here, NLRP3 is linked to cryopyrin-associated periodic syndrome.